Plasbumin Solution
Product Images NDC 13533-692

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasbumin (NDC 13533-692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel

Packaging label for Plasbumin-25, a 25% Albumin (Human) solution for intravenous infusion by Grifols USA, LLC. The label indicates a 12.5 g per 50 mL strength, single-dose vial, with instructions on storage and usage. The label includes branding, NDC number 13533-692-20, lot and expiration date placeholders, and additional product content information.*

FDA Label Image

Viallabel

The label for Plasbumin 12.5 g/50 mL solution for intravenous infusion by Grifols Therapeutics LLC shows the product name, active ingredient Albumin (Human) 25% USP, and specifies a 50 mL single-dose vial. The label includes usage warnings such as not using if turbid, and administration guidelines emphasizing a four-hour time limit after container entry. Storage and discard instructions for unused portions are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.